2025.3.20
- Statements
- Notices
JSRM publishes a paper on recommendations for the safe implementation of intravenous administration of MSCs in Regenerative Therapy
March 20, 2025 – The Japanese Society for Regenerative Medicine (JSRM) announced our paper on the safe intravenous administration of mesenchymal stromal cells (MSCs) has been published in Regenerative Therapy (Vol. 29, 2025).
This publication provides comprehensive recommendations to ensure patient safety, addressing practical protocols for MSC infusion, potential risks including embolic complications, and emphasizing rigorous clinical oversight and monitoring strategies. We believe this will significantly contribute to the global standardization and safe clinical implementation of MSC therapies.
The full article is available at: “Recommendations for the safe implementation of intravenous administration of mesenchymal stromal cells”
For more information, please contact:
Foreign Affairs Office, Japanese Society for Regenerative Medicine
Email: foreignaffairs@jsrm.jp